Information Journal Paper
APA:
Copy. (2017). Phase II trial of adjuvantimmunotherapy with autologous tumor-derivedGp96 vaccination in patients with gastric cancer. JOURNAL OF CANCER, 8(10), 1826-1826. SID. https://sid.ir/paper/709607/en
Vancouver:
Copy. Phase II trial of adjuvantimmunotherapy with autologous tumor-derivedGp96 vaccination in patients with gastric cancer. JOURNAL OF CANCER[Internet]. 2017;8(10):1826-1826. Available from: https://sid.ir/paper/709607/en
IEEE:
Copy, “Phase II trial of adjuvantimmunotherapy with autologous tumor-derivedGp96 vaccination in patients with gastric cancer,” JOURNAL OF CANCER, vol. 8, no. 10, pp. 1826–1826, 2017, [Online]. Available: https://sid.ir/paper/709607/en